6,423
Views
23
CrossRef citations to date
0
Altmetric
Review

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature

ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, , & show all
Pages 1691-1706 | Published online: 15 Jun 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Vivian W. L. Tsang, Dragos C. Ragazan, Pamela Kryskow, Zach Walsh & Shannon Dames. (2023) A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy. Journal of Psychoactive Drugs 0:0, pages 1-10.
Read now
Julia M. K. Freind, Fernando R. Beserra, Bruno S. Menezes & Daniel C. Mograbi. (2023) Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review. Journal of Psychoactive Drugs 0:0, pages 1-17.
Read now
Debora Oliveira, Rodrigo Fontenele, Jeremy Weleff, Mehmet Sofuoglu & Joao P. De Aquino. (2023) Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence. International Review of Psychiatry 0:0, pages 1-20.
Read now

Articles from other publishers (20)

Kyle A. Brown & Todd D. Gould. (2024) Targeting metaplasticity mechanisms to promote sustained antidepressant actions. Molecular Psychiatry.
Crossref
Caroline Peacock, Jennifer S. Mascaro, Erin Brauer, Ali John Zarrabi, Boadie W. Dunlop, Jessica L. Maples-Keller, George H. Grant, Charles L. Raison, Fayzan Rab & Roman Palitsky. (2024) Spiritual health practitioners’ contributions to psychedelic assisted therapy: A qualitative analysis. PLOS ONE 19:1, pages e0296071.
Crossref
Robert Swoap. (2023) Psychedelic Healing: A Historical, Empirical, and Personal Account. American Journal of Health Promotion 38:1, pages 143-148.
Crossref
Jay E. Maddock & Sara S. Johnson. (2023) Spending Time in Nature: The Overlooked Health Behavior. American Journal of Health Promotion 38:1, pages 124-148.
Crossref
Jennifer M. Mitchell & Brian T. Anderson. (2023) Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism. Neuropsychopharmacology 49:1, pages 96-103.
Crossref
John G. Cottone. (2023) Ketamine-Assisted Psychodynamic Psychotherapy. Psychodynamic Psychiatry 51:4, pages 467-478.
Crossref
Alexander Kaltenboeck, Elisa Foerster, Sabrina Strafner, Ulrike Demal, Nilufar Mossaheb & Fabian Friedrich. (2023) Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy. Frontiers in Psychiatry 14.
Crossref
Akash Goel, Bhavya Kapoor, Hillary Chan, Karim Ladha, Joel Katz, Hance Clarke, Janneth Pazmino-Canizares, Zaaria Thomas, Kaylyssa Philip, Gabriella Mattina & Paul Ritvo. (2023) Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain (PSYKED-NP): Protocol for a Randomized Controlled Pilot Trial (Preprint). JMIR Research Protocols.
Crossref
Courtney M. Vecera, Alan C. Courtes, Gregory Jones, Jair C. Soares & Rodrigo Machado-Vieira. (2023) Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression. Pharmaceuticals 16:11, pages 1572.
Crossref
Or Duek, Nachshon Korem, Yutong Li, Ben Kelmendi, Shelley Amen, Charles Gordon, Madison Milne, John H. Krystal, Ifat Levy & Ilan Harpaz-Rotem. (2023) Long term structural and functional neural changes following a single infusion of Ketamine in PTSD. Neuropsychopharmacology 48:11, pages 1648-1658.
Crossref
Abigail Calder, Seline Mock, Nicole Friedli, Patrick Pasi & Gregor Hasler. (2023) Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms. European Neuropsychopharmacology 75, pages 1-14.
Crossref
Wim van den Brink & Jan van Amsterdam. (2023) Progress in treatment‐resistant bipolar depression using repeated ketamine infusions. Bipolar Disorders 25:6, pages 517-518.
Crossref
Juliana Zambrano & Fernando Espi Forcen. (2023) Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression. Journal of Clinical Psychopharmacology 43:5, pages 462-464.
Crossref
Emily Whinkin, Therry Rose J. Eparwa, Michelle C. Julseth, Andrea Schneider & Sunil K. Aggarwal. (2023) Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review. Frontiers in Psychiatry 14.
Crossref
Adelaida Castillo, Julien Dubois, Ryan M. Field, Frank Fishburn, Andrew Gundran, Wilson C. Ho, Sami Jawhar, Julian Kates-Harbeck, Zahra M. Aghajan, Naomi Miller, Katherine L. Perdue, Jake Phillips, Wesley C. Ryan, Mahdi Shafiei, Felix Scholkmann & Moriah Taylor. (2023) Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS. Scientific Reports 13:1.
Crossref
Rachel FremontOneysha BrownAdriana FederJames Murrough. (2023) Ketamine for Treatment of Posttraumatic Stress Disorder: State of the Field. FOCUS 21:3, pages 257-265.
Crossref
Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, Jolien Veraart, Eric Vermetten, Jeanine Kamphuis, Wim van den Brink & Robert Schoevers. (2023) Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study. Psychopharmacology 240:7, pages 1547-1560.
Crossref
Charlotte E. Goldfine, Jeremiah J. Tom, Dana D. Im, Benjamin Yudkoff, Amit Anand, Joseph J. Taylor, Peter R. Chai & Joji Suzuki. (2023) The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review. Frontiers in Psychiatry 14.
Crossref
David S. Mathai, Sandeep M. Nayak, David B. Yaden & Albert Garcia-Romeu. (2023) Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine. Psychopharmacology 240:4, pages 827-836.
Crossref
Joshua Willms, Ben McCauley, Lindsay Kerr, Peyton Presto, Ankith Arun, Nazeen Shah, Kierra Irby, Megan Strawn & Jonathan Kopel. (2022) Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder. Frontiers in Psychiatry 13.
Crossref